IBDEI1I3 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24273,0)
 ;;=E10.641^^82^1050^12
 ;;^UTILITY(U,$J,358.3,24273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24273,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,24273,1,4,0)
 ;;=4^E10.641
 ;;^UTILITY(U,$J,358.3,24273,2)
 ;;=^5002621
 ;;^UTILITY(U,$J,358.3,24274,0)
 ;;=E10.649^^82^1050^13
 ;;^UTILITY(U,$J,358.3,24274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24274,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,24274,1,4,0)
 ;;=4^E10.649
 ;;^UTILITY(U,$J,358.3,24274,2)
 ;;=^5002622
 ;;^UTILITY(U,$J,358.3,24275,0)
 ;;=E10.65^^82^1050^11
 ;;^UTILITY(U,$J,358.3,24275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24275,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,24275,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,24275,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,24276,0)
 ;;=E10.69^^82^1050^25
 ;;^UTILITY(U,$J,358.3,24276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24276,1,3,0)
 ;;=3^DM Type 1 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,24276,1,4,0)
 ;;=4^E10.69
 ;;^UTILITY(U,$J,358.3,24276,2)
 ;;=^5002624
 ;;^UTILITY(U,$J,358.3,24277,0)
 ;;=E10.8^^82^1050^27
 ;;^UTILITY(U,$J,358.3,24277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24277,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Compl
 ;;^UTILITY(U,$J,358.3,24277,1,4,0)
 ;;=4^E10.8
 ;;^UTILITY(U,$J,358.3,24277,2)
 ;;=^5002625
 ;;^UTILITY(U,$J,358.3,24278,0)
 ;;=E10.9^^82^1050^28
 ;;^UTILITY(U,$J,358.3,24278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24278,1,3,0)
 ;;=3^DM Type 1 w/o Compl
 ;;^UTILITY(U,$J,358.3,24278,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,24278,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,24279,0)
 ;;=E11.00^^82^1051^18
 ;;^UTILITY(U,$J,358.3,24279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24279,1,3,0)
 ;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
 ;;^UTILITY(U,$J,358.3,24279,1,4,0)
 ;;=4^E11.00
 ;;^UTILITY(U,$J,358.3,24279,2)
 ;;=^5002627
 ;;^UTILITY(U,$J,358.3,24280,0)
 ;;=E11.01^^82^1051^17
 ;;^UTILITY(U,$J,358.3,24280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24280,1,3,0)
 ;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
 ;;^UTILITY(U,$J,358.3,24280,1,4,0)
 ;;=4^E11.01
 ;;^UTILITY(U,$J,358.3,24280,2)
 ;;=^5002628
 ;;^UTILITY(U,$J,358.3,24281,0)
 ;;=E11.21^^82^1051^6
 ;;^UTILITY(U,$J,358.3,24281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24281,1,3,0)
 ;;=3^DM Type 2 w/ Diab Nephropathy
 ;;^UTILITY(U,$J,358.3,24281,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,24281,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,24282,0)
 ;;=E11.22^^82^1051^3
 ;;^UTILITY(U,$J,358.3,24282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24282,1,3,0)
 ;;=3^DM Type 2 w/ Diab CKD
 ;;^UTILITY(U,$J,358.3,24282,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,24282,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,24283,0)
 ;;=E11.39^^82^1051^27
 ;;^UTILITY(U,$J,358.3,24283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24283,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Ophth Compl
 ;;^UTILITY(U,$J,358.3,24283,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,24283,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,24284,0)
 ;;=E11.41^^82^1051^5
 ;;^UTILITY(U,$J,358.3,24284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24284,1,3,0)
 ;;=3^DM Type 2 w/ Diab Mononeuropathy
 ;;^UTILITY(U,$J,358.3,24284,1,4,0)
 ;;=4^E11.41
 ;;^UTILITY(U,$J,358.3,24284,2)
 ;;=^5002645
 ;;^UTILITY(U,$J,358.3,24285,0)
 ;;=E11.42^^82^1051^12
 ;;^UTILITY(U,$J,358.3,24285,1,0)
 ;;=^358.31IA^4^2
